Re-purposing a cancer therapeutic in combination with a non-steroidal inflammatory drug for the treatment of Respiratory Syncytial Virus.

Medicine & Life Sciences

1. Respiratory Syncytial Viruses 100%
2. Respiratory Syncytial Virus Infections 36%
3. Pharmaceutical Preparations 35%
4. Virus Replication 28%
5. Neoplasms 27%
6. Respiratory Tract Infections 26%
7. Virus Diseases 20%
8. Elderly 19%
9. Viruses 18%
10. Pathology 17%
11. Inflammation 16%
12. Therapeutics 13%
13. Child 12%